Related references
Note: Only part of the references are listed.Recent advances in the developmental origin of neuroblastoma: an overview
Mirco Ponzoni et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory
Xiaojun Yuan et al.
CELL REPORTS (2022)
Plasticity in Neuroblastoma Cell Identity Defines a Noradrenergic-to-Mesenchymal Transition (NMT)
Margot Gautier et al.
CANCERS (2021)
Atypical PKCs activate Vimentin to facilitate prostate cancer cell motility and invasion
Wishrawana S. Ratnayake et al.
CELL ADHESION & MIGRATION (2021)
Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic
Andre H. Apostolatos et al.
ANTI-CANCER DRUGS (2019)
Analysis of PKC- protein levels in normal and malignant breast tissue subtypes
Tracess Smalley et al.
ONCOLOGY LETTERS (2019)
Human Embryonic Kidney 293 Cells: A Vehicle for Biopharmaceutical Manufacturing, Structural Biology, and Electrophysiology
Jianwen Hu et al.
CELLS TISSUES ORGANS (2018)
The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein-protein interactions
K. L. Pennington et al.
ONCOGENE (2018)
Oncogenic PKC- activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC- and PKC- specific inhibitors
Wishrawana S. Ratnayake et al.
CELL ADHESION & MIGRATION (2018)
Neuroblastoma Origin and Therapeutic Targets for Immunotherapy
Irina V. Kholodenko et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
c-Jun and FOXO1 play key roles in the overexpression of oncogenic PKC-I in human prostate and melanoma cell lines
Andre H. Apostolatos et al.
CANCER RESEARCH (2018)
Inhibition of atypical protein kinase C- effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade
Andre H. Apostolatos et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis
Wishrawana S. Ratnayake et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Atypical protein kinase c inhibitors can repress epithelial to mesenchymal transition (type III) in malignant melanoma
Wishrawana Sarathi Ratnayake et al.
CANCER RESEARCH (2017)
Use of ACPD and ICA-1 as inhibitors of atypical proteinkinase (ζ) zeta (I) and iota (I) in metastasized melanoma cells
Wishrawana S. Ratnayake et al.
CANCER RESEARCH (2016)
14-3-3ζ and aPKC-ι synergistically facilitate epithelial-mesenchymal transition of cholangiocarcinoma via GSK-3β/snail signaling pathway
Yan Yang et al.
ONCOTARGET (2016)
14-3-3ζ Turns TGF-β's Function from Tumor Suppressor to Metastasis Promoter in Breast Cancer by Contextual Changes of Smad Partners from p53 to Gli2
Jia Xu et al.
CANCER CELL (2015)
EMT in cervical cancer: Its role in tumour progression and response to therapy
Rehana Qureshi et al.
CANCER LETTERS (2015)
Establishing neural crest identity: a gene regulatory recipe
Marcos Simoes-Costa et al.
DEVELOPMENT (2015)
aPKC alters the TGFβ response in NSCLC cells through both Smad-dependent and Smad-independent pathways
Adrian Gunaratne et al.
JOURNAL OF CELL SCIENCE (2015)
In vitro Cell Migration and Invasion Assays
Calvin R. Justus et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
Insights into neural crest development and evolution from genomic analysis
Marcos Simoes-Costa et al.
GENOME RESEARCH (2013)
Atypical Protein Kinase C Phosphorylates Par6 and Facilitates Transforming Growth Factor β-Induced Epithelial-to-Mesenchymal Transition
Adrian Gunaratne et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Par6 is phosphorylated by aPKC to facilitate EMT
Adrian Gunaratne et al.
CELL ADHESION & MIGRATION (2013)
Epithelial to mesenchymal transition (EMT) biomarkers - E-cadherin, beta-catenin, APC and Vimentin - in oral squamous cell carcinogenesis and transformation
S. Y. Chaw et al.
ORAL ONCOLOGY (2012)
A novel PKC-ι inhibitor abrogates cell proliferation and induces apoptosis in neuroblastoma
Prajit Pillai et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Protein Kinase Cι Expression and Oncogenic Signaling Mechanisms in Cancer
Nicole R. Murray et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
14-3-3 Proteins: Diverse functions in cell proliferation and cancer progression
Alyson K. Freeman et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2011)
Protein Kinase Cι Is Required for Pancreatic Cancer Cell Transformed Growth and Tumorigenesis
Michele L. Scotti et al.
CANCER RESEARCH (2010)
Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition
Melissa G. Mendez et al.
FASEB JOURNAL (2010)
Patterning N-type and S-type neuroblastoma cells with Pluronic F108 and ECM proteins
Joseph M. Corey et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2010)
Expression of Protein Kinase C Family in Human Hepatocellular Carcinoma
Hsiu-Chin Lu et al.
PATHOLOGY & ONCOLOGY RESEARCH (2010)
Stabilization of Snail by NF-κB Is Required for Inflammation-Induced Cell Migration and Invasion
Yadi Wu et al.
CANCER CELL (2009)
Trk Receptor Expression and Inhibition in Neuroblastomas
Garrett M. Brodeur et al.
CLINICAL CANCER RESEARCH (2009)
New Therapeutic Targets for the Treatment of High-Risk Neuroblastoma
Lars M. Wagner et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Atypical protein kinase C phosphorylates IKKαβ in transformed non-malignant and malignant prostate cell survival
Hla Y. Win et al.
CANCER LETTERS (2008)
Molecular concepts analysis links tumors, pathways, mechanisms, and drugs
Daniel R. Rhodes et al.
NEOPLASIA (2007)
Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer
Meera Nanjundan et al.
CANCER RESEARCH (2007)
A Wnt-Axin2-GSK3β cascade regulates Snail1 activity in breast cancer cells
Jong In Yook et al.
NATURE CELL BIOLOGY (2006)
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays
M Sanchez-Carbayo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Reverse engineering of regulatory networks in human B cells
K Basso et al.
NATURE GENETICS (2005)
Characteristics of stem cells from human neuroblastoma cell lines and in tumors
JD Walton et al.
NEOPLASIA (2004)
Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during puberty
SM Dhanasekaran et al.
FASEB JOURNAL (2004)
Phosphorylation-dependent binding of 14-3-3 to the polarity protein Par3 regulates cell polarity in mammalian epithelia
TW Hurd et al.
CURRENT BIOLOGY (2003)
A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors
RA Ross et al.
CANCER LETTERS (2003)
Identification of three novel Smad binding proteins involved in cell polarity
DR Warner et al.
FEBS LETTERS (2003)